Trial Profile
An Open-label, Randomized, Single-dose Crossover Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CJ-30060 in Healthy Subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2020
Price :
$35
*
At a glance
- Drugs Amlodipine/rosuvastatin/valsartan (Primary) ; Amlodipine/valsartan (Primary) ; Rosuvastatin (Primary)
- Indications Hyperlipidaemia; Hypertension
- Focus Pharmacokinetics
- Sponsors HK inno.N
- 04 Dec 2018 New trial record